MUCOPOLYSACCHARIDOSIS III

Clinical trials for MUCOPOLYSACCHARIDOSIS III explained in plain language.

Never miss a new study

Get alerted when new MUCOPOLYSACCHARIDOSIS III trials appear

Sign up with your email to follow new studies for MUCOPOLYSACCHARIDOSIS III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1

Could cannabis compound calm symptoms of devastating childhood disease?

Symptom relief Not yet recruiting

This study aims to see if a purified form of cannabidiol (CBD), a compound from the cannabis plant, can safely help manage the difficult behavioral symptoms and improve daily functioning in children with Sanfilippo syndrome, a rare and severe genetic disorder. About 35 participan…

Matched conditions: MUCOPOLYSACCHARIDOSIS III

Phase: PHASE2, PHASE3 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Symptom relief

Last updated Apr 02, 2026 02:41 UTC

MUCOPOLYSACCHARIDOSIS III

Get alerted when new MUCOPOLYSACCHARIDOSIS III trials appear

Could cannabis compound calm symptoms of devastating childhood disease?